Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Patent
1987-09-24
1991-06-04
Springer, David B.
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
540474, 546169, C07D40306, C07D40302
Patent
active
050215671
ABSTRACT:
The present invention provides linear, cyclic and trifurcate tri- and tetramine backbone multidentate chelating agents based on the 8-hydroxyquinoline chelating unit. The chelating agents may optionally be substituted with a substate reactive moiety and antibody-metal ion conjugates may be produced for in vivo diagnostic and therapeutic methods.
REFERENCES:
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4181654 (1980-01-01), Weitl et al.
patent: 4309305 (1982-01-01), Weitl et al.
patent: 4421654 (1983-12-01), Plueddmann
patent: 4442305 (1984-04-01), Weitl et al.
patent: 4454106 (1984-06-01), Gansow et al.
patent: 4500494 (1985-02-01), Scher
patent: 4543213 (1985-09-01), Weitl et al.
patent: 4671958 (1987-06-01), Rodwell et al.
J. Med. Chem, 1987, 30, 1987-1900, Yamato et al., Synthesis and Antitumor Activity of Tropolone Derivatives.
Advanced Inorganic Chemistry, F. A. Cotton and G. Wilkinson, 4th Edition, pp. 71-73, 1980.
Harris et al., J. Amer. Chem. Soc., 101, 6097 (1979).
Jain et al., J. Amer. Chem. Soc., 89, 724 (1967).
J. Amer. Chem. Soc., 90, 519 (1968).
Rodgers et al., Inorgn. Chem., 26 1622 (1987).
Sundberg et al., J. Med. Chem., 17, 1304 (1974).
McAfee et al., J. Nucl. Med., 17, 480 (1976).
Moerlein et al., Int. J. Nucl. Med. Biol., 8, 277 (1981).
Hata et al., Bull. Chim. Soc. Japan, 45, 477 (1972).
Goldenberg et al., N. Eng. J. Med., 298, 1384-88 (1978).
Order et al., Int. J. Radiation Oncology Biol. Phys. 12, 277-81 (1986).
Buchsbaum et al., Int. J. Nucl. Med. Biol., vol. 12, No. 2, pp. 79-82 (1985).
Wang et al., Inorg. Chem. 28, 723 (1987).
Sim et al., Inorg. Chem. 17, 1288 (1978).
Wilson et al., J. Amer. Chem. Soc., 90, 6041 (1968).
Rosenberg et al., Biochemistry, 11, 3623-28 (1972).
Hwang and Wase, Biochim. Biophys. Acta, 512, 54-71 (1978).
Zittle, Advan. Enzyme. 12, 493 (1951).
Burnett et al., Biochem. Biophys. Res. Comm., 96, 157-62 (1980).
Zalcberg & McKenzie, J. Clin. Oncology, vol. 3, pp. 876-882 (1985).
Morrison et al., Proc. Nat. Acad. Sci. U.S.A., 81, 6851-55 (1984).
Porath and Olin, Biochemistry, 22, 1621-30 (1983).
DeRiemer et al., J. Med. Chem. 22, 1019-23, (1979).
Goodwin et al., J. Nucl. Med., 22, 787-92 (1981).
Haner et al., Arch. Biochem. Biophys., 231, 477-86 (1984).
Schultz and Dervan, J. Amer. Chem. Soc., 105, 7748-50 (1983).
Meares et al., Anal. Biochem., 142, 68 (1984).
Johnson David K.
Kline Steven J.
Abbott Laboratories
Curry Daniel R.
Springer David B.
LandOfFree
8-hydroxyquinoline chelating agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 8-hydroxyquinoline chelating agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 8-hydroxyquinoline chelating agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1027817